Literature DB >> 30376970

[ST-elevation myocardial infarction (STEMI) in the elderly].

Z Terzian1, M Slama2.   

Abstract

Admission in cardiology departments of patients over 80 years old, even nonagenarians, for ST-segment elevation myocardial infarction (STEMI) is not uncommon in 2018. The management of these high risk and polypathological patients, with atypical clinical presentation, is not based on international guidelines or randomized studies, but rather on retrospective studies, expert consensus, and common sense. Each decision has to be individualized to the patient's situation. This review, after a clinical case, aims to guide the clinician in the specific management of these patients, from the symptoms, to reperfusion strategy, and, as fast as possible, hospital discharge.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antithrombotic therapy; Antithrombotiques; Elderly; ST-elevation myocardial infarction; Sujet âgé; Syndrome coronaire aigu avec sus-décalage du segment ST

Mesh:

Substances:

Year:  2018        PMID: 30376970     DOI: 10.1016/j.ancard.2018.10.003

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  1 in total

1.  Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI.

Authors:  LiMing Xue; Xian Yuan; Shuguang Zhang; Xia Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-15       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.